FCGR3A and metabolic syndrome: In addition, morbid obesity in MetS is associated with a meta-inflammatory response and the development of cardiovascular complications—specifically, with the transition from inflammatory classical CD14+CD16- monocytes to anti-inflammatory non-classical CD14dimCD16+ monocytes.